FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1985456066> ?p ?o ?g. }

• W1985456066 endingPage "1733" @default.
• W1985456066 startingPage "1726" @default.
• W1985456066 abstract "Capecitabine is an established treatment alternative to intravenous 5-fluorouracil (5-FU) for patients with rectal cancer receiving chemoradiotherapy. Its place in the treatment of locally advanced anal carcinoma (AC), however, remains undetermined. We investigated whether capecitabine is as effective as 5-FU in the treatment of patients with locally advanced AC.One hundred and five patients with squamous cell AC stage T2-4 (T2>4 cm), N0-1, M0 or T1-4, N2-3, M0, were included in this retrospective study. Forty-seven patients were treated with continuous 5-FU (750 mg m(-2)) on days 1-5 and 29-33, mitomycin C (MMC, 10 mg m(-2)) on day 1, and radiotherapy; 58 patients were treated with capecitabine (825 mg m(-2) b.i.d. on weekdays), MMC (10 mg m(-2)) on day 1, and radiotherapy. The primary end points of the study were: clinical complete response rate, locoregional control (LRC) and overall survival (OS). Secondary end points were: colostomy-free survival (CFS), toxicity and associations of genetic polymorphisms (GSTT1, GSTM1, GSTP1 and TYMS) with outcome and toxicity.Clinical complete response was achieved in 41/46 patients (89.1%) with 5-FU and in 52/58 patients (89.7%) with capecitabine. Three-year LRC was 76% and 79% (P=0.690, log-rank test), 3-year OS was 78% and 86% (P=0.364, log-rank test) and CFS was 65% and 79% (P=0.115, log-rank test) for 5-FU and capecitabine, respectively. GSTT1 and TYMS genotypes were associated with severe (grade 3-4) toxicity.Capecitabine combined with MMC and radiotherapy was equally effective as 5-FU-based chemoradiotherapy. This study shows that capecitabine can be used as an acceptable alternative to 5-FU for the treatment of AC." @default.
• W1985456066 created "2016-06-24" @default.
• W1985456066 creator A5000418012 @default.
• W1985456066 creator A5017478217 @default.
• W1985456066 creator A5026190762 @default.
• W1985456066 creator A5031176507 @default.
• W1985456066 creator A5052900822 @default.
• W1985456066 creator A5056239566 @default.
• W1985456066 creator A5062227574 @default.
• W1985456066 date "2014-08-28" @default.
• W1985456066 modified "2023-10-09" @default.
• W1985456066 title "Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option" @default.
• W1985456066 cites W1804130247 @default.
• W1985456066 cites W1916782931 @default.
• W1985456066 cites W1994549225 @default.
• W1985456066 cites W1994934546 @default.
• W1985456066 cites W2001337137 @default.
• W1985456066 cites W2015599354 @default.
• W1985456066 cites W2023667505 @default.
• W1985456066 cites W2029517266 @default.
• W1985456066 cites W2033279693 @default.
• W1985456066 cites W2056582801 @default.
• W1985456066 cites W2065565788 @default.
• W1985456066 cites W2067126590 @default.
• W1985456066 cites W2093670250 @default.
• W1985456066 cites W2096689681 @default.
• W1985456066 cites W2098584035 @default.
• W1985456066 cites W2134187029 @default.
• W1985456066 cites W2137194656 @default.
• W1985456066 cites W2158244375 @default.
• W1985456066 cites W2164644812 @default.
• W1985456066 cites W776995397 @default.
• W1985456066 doi "https://doi.org/10.1038/bjc.2014.467" @default.
• W1985456066 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4453727" @default.
• W1985456066 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25167226" @default.
• W1985456066 hasPublicationYear "2014" @default.
• W1985456066 type Work @default.
• W1985456066 sameAs 1985456066 @default.
• W1985456066 citedByCount "69" @default.
• W1985456066 countsByYear W19854560662015 @default.
• W1985456066 countsByYear W19854560662016 @default.
• W1985456066 countsByYear W19854560662017 @default.
• W1985456066 countsByYear W19854560662018 @default.
• W1985456066 countsByYear W19854560662019 @default.
• W1985456066 countsByYear W19854560662020 @default.
• W1985456066 countsByYear W19854560662021 @default.
• W1985456066 countsByYear W19854560662022 @default.
• W1985456066 countsByYear W19854560662023 @default.
• W1985456066 crossrefType "journal-article" @default.
• W1985456066 hasAuthorship W1985456066A5000418012 @default.
• W1985456066 hasAuthorship W1985456066A5017478217 @default.
• W1985456066 hasAuthorship W1985456066A5026190762 @default.
• W1985456066 hasAuthorship W1985456066A5031176507 @default.
• W1985456066 hasAuthorship W1985456066A5052900822 @default.
• W1985456066 hasAuthorship W1985456066A5056239566 @default.
• W1985456066 hasAuthorship W1985456066A5062227574 @default.
• W1985456066 hasBestOaLocation W19854560661 @default.
• W1985456066 hasConcept C10515644 @default.
• W1985456066 hasConcept C121608353 @default.
• W1985456066 hasConcept C126322002 @default.
• W1985456066 hasConcept C141071460 @default.
• W1985456066 hasConcept C143998085 @default.
• W1985456066 hasConcept C2777909004 @default.
• W1985456066 hasConcept C2778424827 @default.
• W1985456066 hasConcept C2778496288 @default.
• W1985456066 hasConcept C2779840525 @default.
• W1985456066 hasConcept C2780456651 @default.
• W1985456066 hasConcept C509974204 @default.
• W1985456066 hasConcept C526805850 @default.
• W1985456066 hasConcept C66339696 @default.
• W1985456066 hasConcept C71924100 @default.
• W1985456066 hasConcept C90924648 @default.
• W1985456066 hasConceptScore W1985456066C10515644 @default.
• W1985456066 hasConceptScore W1985456066C121608353 @default.
• W1985456066 hasConceptScore W1985456066C126322002 @default.
• W1985456066 hasConceptScore W1985456066C141071460 @default.
• W1985456066 hasConceptScore W1985456066C143998085 @default.
• W1985456066 hasConceptScore W1985456066C2777909004 @default.
• W1985456066 hasConceptScore W1985456066C2778424827 @default.
• W1985456066 hasConceptScore W1985456066C2778496288 @default.
• W1985456066 hasConceptScore W1985456066C2779840525 @default.
• W1985456066 hasConceptScore W1985456066C2780456651 @default.
• W1985456066 hasConceptScore W1985456066C509974204 @default.
• W1985456066 hasConceptScore W1985456066C526805850 @default.
• W1985456066 hasConceptScore W1985456066C66339696 @default.
• W1985456066 hasConceptScore W1985456066C71924100 @default.
• W1985456066 hasConceptScore W1985456066C90924648 @default.
• W1985456066 hasIssue "9" @default.
• W1985456066 hasLocation W19854560661 @default.
• W1985456066 hasLocation W19854560662 @default.
• W1985456066 hasLocation W19854560663 @default.
• W1985456066 hasLocation W19854560664 @default.
• W1985456066 hasLocation W19854560665 @default.
• W1985456066 hasOpenAccess W1985456066 @default.
• W1985456066 hasPrimaryLocation W19854560661 @default.
• W1985456066 hasRelatedWork W1983052552 @default.
• W1985456066 hasRelatedWork W1985456066 @default.
• W1985456066 hasRelatedWork W2004150533 @default.

• next